VOYA Investment Management
MRSN

VOYA Investment Management’s Mersana Therapeutics MRSN Stock Holding History

VOYA Investment Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-405
Closed -$3.48K – 2712
2025
Q1 		$3.48K Sell
405
-1,043
-72% -$16.1K ﹤0.01% 2635
2024
Q4 		$51.8K Sell
1,448
-84
-5% -$4.34K ﹤0.01% 2679
2024
Q3 		$72.4K Sell
1,532
-12
-0.8% -$529 ﹤0.01% 2718
2024
Q2 		$77.6K Buy
1,544
+83
+6% +$6K ﹤0.01% 2730
2024
Q1 		$164K Sell
1,461
-380
-21% -$37.8K ﹤0.01% 2516
2023
Q4 		$107K Buy
1,841
+96
+6% +$3.86K ﹤0.01% 2741
2023
Q3 		$55.4K Sell
1,745
-523
-23% -$24.9K ﹤0.01% 2842
2023
Q2 		$187K Sell
2,268
-17,818
-89% -$2.61M ﹤0.01% 2614
2023
Q1 		$2.06M Buy
20,086
+8,610
+75% +$1.21M ﹤0.01% 1346
2022
Q4 		$1.68M Buy
11,476
+1,905
+20% +$322K ﹤0.01% 1402
2022
Q3 		$1.62M Buy
9,571
+8,244
+621% +$1.34M ﹤0.01% 1411
2022
Q2 		$153K Buy
1,327
+274
+26% +$25.8K ﹤0.01% 2500
2022
Q1 		$105K Hold
1,053
– – ﹤0.01% 2510
2021
Q4 		$164K Sell
1,053
-5
-0.5% -$973 ﹤0.01% 2572
2021
Q3 		$249K Hold
1,058
– – ﹤0.01% 2446
2021
Q2 		$359K Buy
1,058
+140
+15% +$53K ﹤0.01% 2287
2021
Q1 		$371K Sell
918
-4
-0.4% -$1.94K ﹤0.01% 2191
2020
Q4 		$614K Buy
922
+204
+28% +$113K ﹤0.01% 1786
2020
Q3 		$334K Buy
718
+81
+13% +$40.9K ﹤0.01% 1882
2020
Q2 		$372K Sell
637
-122
-16% -$41.7K ﹤0.01% 1846
2020
Q1 		$111K Hold
759
– – ﹤0.01% 2316
2019
Q4 		$109K Buy
759
+236
+45% +$17.3K ﹤0.01% 2524
2019
Q3 		$21K Hold
523
– – ﹤0.01% 2542
2019
Q2 		$53K Buy
+523
New +$61.6K ﹤0.01% 2557

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VOYA Investment Management's MRSN Position: Q2 2025 in Review

VOYA Investment Management sold out of Mersana Therapeutics (MRSN) in Q2 2025, closing a stake of 405 shares — an estimated $3.48K sold.

VOYA Investment Management first reported a position in MRSN in Q2 2019 and held it in 24 quarters. The position peaked at $2.06M in Q1 2023. 83 funds tracked by Wall St. Rank hold MRSN as of Q2 2025.

  • VOYA Investment Management reported no remaining Mersana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 405 Mersana Therapeutics shares in Q2 2025, an estimated $3.48K.
  • VOYA Investment Management first reported a position in Mersana Therapeutics in Q2 2019 and held it in 24 quarters.
  • VOYA Investment Management's Mersana Therapeutics position peaked at $2.06M in Q1 2023.
  • 83 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.